Latest Earnings
Equities
Stock Analysis
Stock Movers
Deals
Gainers And Losers
IPOs
Technology
Artificial Intelligence
Web Stories
Benzinga Inspire
ChemistFrog
Benzinga Contributor
OncoSec Medical to Wrap up 2013 With Multiple Possible Catalysts
Imminent Catalyst for Idera Pharmacueticals Should Garner Positive Investor Interest
The Battle of IL-12 Administration For Cancer Treatment: Is It Really A Battle?
Investments in "Medical Science Fiction"
Multiple Antigen Targeting Could Mean Multiple Marketing for These Immunotherapy Drugs
Stem Cell Biotechs: A Frontrunner Emerges?
ImmunoCellular's Intellectual Property Steadily Increases
Verastem IPO Launch Captures Investors Attention
